" Clonazepam and Lorazepam in methamphetamine poisoning"

Comparison of Clonazepam and Lorazepam in the Treatment of Methamphetamine-Poisoned Children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180610040036N2

Enrollment

Registered

2020-04-18

Start date

2016-03-20

Completion date

Unknown

Last updated

2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methamphetamine poisoning. Other stimulant abuse with intoxication

Interventions

Intervention 1: Intervention group 1: Oral Clonazepam. Intervention 2: Intervention group 2: Oral Lorazepam.

Eligibility

Sex/Gender

All

Age

6 Months to 144 Months

Inclusion criteria

Inclusion criteria: Methamphetamine-Poisoned Children under 12-year-old age

Exclusion criteria

Exclusion criteria: multiple-drug poisoning

Design outcomes

Primary

Measure	Time frame
Agitation level. Timepoint: Admission time, 6,12,18,24 hours. Method of measurement: questionnaire (Richmond Agitation).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Hassanian-Moghaddam

Shahid Beheshti University of Medical Sciences

hasanian2000@yahoo.com+98 21 5102 5182

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 25, 2026